Choueiri TK - Search Results

1

Renal-cell carcinoma: a step closer to a new classification.

Choueiri TK, Pomerantz MM, Signoretti S. Choueiri TK, et al. Lancet Oncol. 2013 Feb;14(2):105-7. doi: 10.1016/S1470-2045(12)70599-5. Epub 2013 Jan 16. Lancet Oncol. 2013. PMID: 23333115 No abstract available.

2

An association between renal cell carcinoma and multiple myeloma: a case series and clinical implications.

Choueiri TK, Baz RC, McFadden CM, Khasawneh M, Karam MA, Kelly M, Hussein MA. Choueiri TK, et al. BJU Int. 2008 Mar;101(6):712-5. doi: 10.1111/j.1464-410X.2007.07268.x. Epub 2007 Oct 26. BJU Int. 2008. PMID: 17970789

3

Efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma.

Choueiri TK, Plantade A, Elson P, Negrier S, Ravaud A, Oudard S, Zhou M, Rini BI, Bukowski RM, Escudier B. Choueiri TK, et al. J Clin Oncol. 2008 Jan 1;26(1):127-31. doi: 10.1200/JCO.2007.13.3223. J Clin Oncol. 2008. PMID: 18165647

4

Factors associated with outcome in patients with advanced renal cell carcinoma in the era of antiangiogenic agents.

Choueiri TK. Choueiri TK. Clin Genitourin Cancer. 2008 Mar;6(1):15-20. doi: 10.3816/CGC.2008.n.002. Clin Genitourin Cancer. 2008. PMID: 18501077 Review.

5

Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy.

Choueiri TK, Xie W, D'Amico AV, Ross RW, Hu JC, Pomerantz M, Regan MM, Taplin ME, Kantoff PW, Sartor O, Oh WK. Choueiri TK, et al. Cancer. 2009 Mar 1;115(5):981-7. doi: 10.1002/cncr.24064. Cancer. 2009. PMID: 19152438 Free PMC article.

6

Optimizing recent advances in metastatic renal cell carcinoma.

Courtney KD, Choueiri TK. Courtney KD, et al. Among authors: choueiri tk. Curr Oncol Rep. 2009 May;11(3):218-26. doi: 10.1007/s11912-009-0031-5. Curr Oncol Rep. 2009. PMID: 19336014 Review.

7

Treatment selection for patients with metastatic renal cell carcinoma.

Atkins MB, Choueiri TK, Cho D, Regan M, Signoretti S. Atkins MB, et al. Among authors: choueiri tk. Cancer. 2009 May 15;115(10 Suppl):2327-33. doi: 10.1002/cncr.24231. Cancer. 2009. PMID: 19402069 Free PMC article. Review.

8

Risk of bilateral renal cell cancer.

Wiklund F, Tretli S, Choueiri TK, Signoretti S, Fall K, Adami HO. Wiklund F, et al. Among authors: choueiri tk. J Clin Oncol. 2009 Aug 10;27(23):3737-41. doi: 10.1200/JCO.2008.20.6524. Epub 2009 Jul 13. J Clin Oncol. 2009. PMID: 19597028

9

Sunitinib in renal-cell carcinoma: expanded indications.

Choueiri TK, Bellmunt J. Choueiri TK, et al. Lancet Oncol. 2009 Aug;10(8):740. doi: 10.1016/S1470-2045(09)70185-8. Epub 2009 Jul 15. Lancet Oncol. 2009. PMID: 19615941 Review. No abstract available.

10

Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials.

Je Y, Schutz FA, Choueiri TK. Je Y, et al. Among authors: choueiri tk. Lancet Oncol. 2009 Oct;10(10):967-74. doi: 10.1016/S1470-2045(09)70222-0. Epub 2009 Sep 18. Lancet Oncol. 2009. PMID: 19767240 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

823 results

Search Page

Filters